youtube_live
Intäkter Q2 2027 • om 5 dagar
Visa informationchevron_right
RDY:NYSE
Dr Reddy's Laboratories Ltd
13,07Â US$
arrow_upward
+1,32%(+0,17) 1 d
13,07Â US$
0,00% (0,00)
bedtimeEfter stängning
Stängd: 16 okt., 16:00:07 GMT−4 · USD
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för RDY …
Öppen
13,00Â US$
Högt
13,07Â US$
LÃ¥gt
12,94Â US$
Börsvärde
10,81Â md
Genomsn. vol.
3,19Â mn
Volym
2,79Â mn
Utdelning
0,64Â %
Kvartalsvis utdelning
0,02Â US$
Ex-utdelningsdatum
10 juli 2026
P/E-tal
31,34
52v högst
15,67Â US$
52v lägst
11,36Â US$
EPS
0,42Â US$
Beta
0,30
Utestående aktier
834,64Â mn
Antal anställda
28Â tn
Öppen
13,00Â US$
Högt
13,07Â US$
LÃ¥gt
12,94Â US$
Börsvärde
10,81Â md
Genomsn. vol.
3,19Â mn
Volym
2,79Â mn
Utdelning
0,64Â %
Kvartalsvis utdelning
0,02Â US$
Ex-utdelningsdatum
10 juli 2026
P/E-tal
31,34
52v högst
15,67Â US$
52v lägst
11,36Â US$
EPS
0,42Â US$
Beta
0,30
Utestående aktier
834,64Â mn
Antal anställda
28Â tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
ad-hoc-news.de
·
för 3 dagar sedan
Dr Reddy reports three FDA observations: what it means for Dr Reddy stock
MarketBeat
·
för 3 dagar sedan
Dr. Reddy's Laboratories (NYSE:RDY) Shares Cross Above Two Hundred Day Moving Average - Time to Sell?
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Om Dr Reddy's Laboratories Ltd
VdErez Israeli
Anställda27,5 tn
Grundades1984
HuvudkontorHyderabad, Andhra Pradesh, Indien
Sektor-
Webbplatsdrreddys.com